{
  "url": "https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019/regulation-25",
  "json_url": "https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019/regulation-25.json",
  "legislation": "ukdsi/2019/9780111179116",
  "legislation_title": "The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019",
  "legislation_url": "https://openlegislation.uk/draft-medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019",
  "path": "regulation/25",
  "kind": "regulation",
  "number": "25",
  "heading": "Amendment of Schedule 7 (standard provisions for manufacturing authorisations)",
  "text": "In Part 1 of Schedule 7, in the definition of “product specification”, omit “or any equivalent provisions in any EEA State other than the United Kingdom”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/ukdsi/2019/9780111179116/regulation/25",
    "retrieved_at": "2026-10-30T15:01:33.158857+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}